Author: p598801

Excellent Response With Alpelisib and Bicalutamide for Advanced Salivary Duct Carcinoma With PIK3CA Mutation and High Androgen Receptor Expression-A Case Report

Development and validation of a multigene variant profiling assay to guide targeted and immuno therapy selection in solid tumors

Improved Treatment Outcomes by Using Patient Specific Drug Combinations in Mammalian Target of Rapamycin Activated Advanced Metastatic Cancers

Angiogenesis Inhibitors in Personalized Combination Regimens for the Treatment of Advanced Refractory Cancers

Evaluation of Circulating Tumor Cell Clusters for Pan-Cancer Noninvasive Diagnostic Triaging

Hallmark Circulating Tumor-Associated Cell Clusters Signify 230 Times Higher One-Year Cancer Risk

A case report of androgen receptor inhibitor therapy in recurrent high-grade serous ovarian cancer

Clinical utility of circulating tumor‑associated cells to predict and monitor chemo‑response in solid tumors

Long Overall Survival in a Case of Refractory Stage IV Squamous Cell Carcinoma of Lung Treated with Personalized De Novo Combination Regimen

MKOT – Precision Oncology Symposium Sept. 2021

In September 2021, Dr. Stefan Schuster gave a talk on the results interpretation of exacta to 180 oncologists at the MKOT Symposium. Videos and pictures of the event can be found here: MKOT Symposium 2021 #personalizedmedicine #liquidbiopsy #oncology #cancer #diagnostics